| Price and Chart delayed at least 15 mintues. |
|
Price
$ 37.10
|
Change
0.00
|
|
Open
0.00
|
% Change
0.0%
|
|
Prev Close
37.10
|
Volume
NA
|
|
Market Value
6 bil
|
P/E Ratio
14.2
|
|
Bid
0.00
|
EPS
2.62
|
|
Ask
0.00
|
Dividend
0.00
|
|
High
0.00
|
Yield
0.0
|
|
Low
0.00
|
Shares Out
160 mil
|
|
52wk High
41.22
|
52wk Low
21.21
|
|
Industry: Drug Delivery
|
|
Sector: Healthcare
|
HSP Profile
A global specialty pharmaceutical and medication delivery company that develops, manufactures and markets products that help improve the safety, cost and productivity of patient care.
Hospira Inc
275 North Field Drive
Lake Forest, IL 60045
Phone: (224) 212-2000
Fax:
Web Site: www.hospira.com
HSP Wires Headlines
|
|
| 07.02.09 |
|
Final Glance: Pharmaceuticals companies
|
|
| 07.02.09 |
|
Final Glance: Medical Devices companies
|
|
| 07.02.09 |
|
Midday Glance: Pharmaceuticals companies
|
|
| 07.02.09 |
|
Midday Glance: Medical Devices companies
|
|
| 07.02.09 |
|
Early Glance: Pharmaceuticals companies
|
More HSP From Wires Headlines >
Forbes.com on HSP RSS
No news found in the past 30 days.HSP Press Releases
|
|
| 06.30.09 |
|
Hospira Announces New Contract With MedAssets for Intravenous Solutions, Renewal of Infusion... |
|
| 06.18.09 |
|
Hospira Receives Favorable Court Decision on Eloxatin(R) |
More HSP Press Releases >
HSP Ratios & Returns
| Price-to-sales |
1.65 |
| Return on Equity |
21.7 |
| Operating Margin |
21.5 |
| Profit Margin |
11.7% |
More HSP Ratios & Returns >
HSP Financials
| Sales |
$3.6005 bil |
| Profits |
$0.421 bil |
| Assets |
$5.0857 bil |
| Employees |
14500.0 |
|
|
|
Hospira is ranked # 1537 on the 2009 Forbes 2000 List
|
|
Thomson / IBES Earnings Estimates on HSP
Accounting Risk
Buy/Hold/Sell Analysis
Forbes Investment Guru Commentary on HSP
RSS News Feed on HSP
|
A D V E R T I S E M E N T
|